{
  "resourceType" : "CodeSystem",
  "id" : "HIV.Configuration",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-insensitive code system <code>http://worldhealthorganization.github.io/smart-hiv/CodeSystem/HIV.Configuration</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">DE1<a name=\"HIV.Configuration-DE1\"> </a></td><td>Population prevalence of TB</td><td>The tuberculosis prevalence in the general population in number of cases per 100 000 persons or greater.</td></tr><tr><td style=\"white-space:nowrap\">DE2<a name=\"HIV.Configuration-DE2\"> </a></td><td>Population prevalence of soil-transmitted helminth infection</td><td>The percentage of individuals in the general population infected with at least one species of soil-transmitted helminths</td></tr><tr><td style=\"white-space:nowrap\">DE3<a name=\"HIV.Configuration-DE3\"> </a></td><td>Population incidence of HIV in the absence of PrEP</td><td>HIV incidence number of cases per 100 person–years in the absence of PrEP</td></tr><tr><td style=\"white-space:nowrap\">DE4<a name=\"HIV.Configuration-DE4\"> </a></td><td>Population prevalence of HIV</td><td>The proportion of the population that are HIV-positive</td></tr><tr><td style=\"white-space:nowrap\">DE5<a name=\"HIV.Configuration-DE5\"> </a></td><td>Prevalence of pretreatment NNRTI drug resistance</td><td>Prevalence of pretreatment HIV drug resistance to NNRTIs among people initiating first-line ART</td></tr><tr><td style=\"white-space:nowrap\">DE6<a name=\"HIV.Configuration-DE6\"> </a></td><td>Malaria-endemic setting</td><td>Whether the setting is a malaria-endemic setting</td></tr><tr><td style=\"white-space:nowrap\">DE7<a name=\"HIV.Configuration-DE7\"> </a></td><td>Population prevalence of syphilis</td><td>The proportion of the population with syphilis</td></tr><tr><td style=\"white-space:nowrap\">DE8<a name=\"HIV.Configuration-DE8\"> </a></td><td>Population prevalence of hepatitis B</td><td>The proportion of hepatitis B surface antigen (HBsAg) seroprevalence in the general population</td></tr><tr><td style=\"white-space:nowrap\">DE9<a name=\"HIV.Configuration-DE9\"> </a></td><td>Population prevalence of hepatitis C</td><td>The proportion of hepatitis C virus (HCV) antibody seroprevalence in the general population</td></tr><tr><td style=\"white-space:nowrap\">DE10<a name=\"HIV.Configuration-DE10\"> </a></td><td>Prevalence of HIV in the catchment area</td><td>The proportion of the population from the health facility's catchment area that are HIV-positive (estimated)</td></tr><tr><td style=\"white-space:nowrap\">DE11<a name=\"HIV.Configuration-DE11\"> </a></td><td>Ultrasound available at the health facility</td><td>Whether an ultrasound machine is available and functional in the facility and a trained health worker is available to use it</td></tr><tr><td style=\"white-space:nowrap\">DE12<a name=\"HIV.Configuration-DE12\"> </a></td><td>HIV burden of the setting</td><td>HIV burden of the setting (high or low) based on the national HIV prevalence or where the HIV prevalence and/or incidence in a geographical setting is higher than national prevalence and, therefore, needs priority in the HIV response</td></tr><tr><td style=\"white-space:nowrap\">DE13<a name=\"HIV.Configuration-DE13\"> </a></td><td>High HIV burden setting</td><td>Settings with &gt;5% national HIV prevalence and subpopulations and geographic settings where HIV prevalence and/or incidence is higher than nationally.</td></tr><tr><td style=\"white-space:nowrap\">DE14<a name=\"HIV.Configuration-DE14\"> </a></td><td>Low HIV burden setting</td><td>Settings with &lt;5% HIV national prevalence but where certain populations (primarily key populations and their partners) and geographic settings may have higher HIV prevalence and/or incidence than nationally and, therefore, need priority in the HIV response</td></tr><tr><td style=\"white-space:nowrap\">DE15<a name=\"HIV.Configuration-DE15\"> </a></td><td>HPV DNA testing operational at the health facility</td><td>Is HPV DNA testing operational at the health facility for cervical cancer screening?</td></tr><tr><td style=\"white-space:nowrap\">DE16<a name=\"HIV.Configuration-DE16\"> </a></td><td>Routine viral load testing is available</td><td>Routine viral load testing is available in the facility</td></tr><tr><td style=\"white-space:nowrap\">DE17<a name=\"HIV.Configuration-DE17\"> </a></td><td>Health facility ID</td><td>Unique ID of the health facility that recorded the client. This ID could represent a universal health facility ID, if used in the country. Alternatively this ID can also be generated by the national surveillance system and assigned to reporting facility.</td></tr><tr><td style=\"white-space:nowrap\">DE18<a name=\"HIV.Configuration-DE18\"> </a></td><td>TB treating facility ID</td><td>The facility where the client is receiving tuberculosis (TB) treatment</td></tr><tr><td style=\"white-space:nowrap\">DE19<a name=\"HIV.Configuration-DE19\"> </a></td><td>Other priority populations</td><td>Other populations of priority of HIV prevention and care in local context (provided during adaptation)</td></tr><tr><td style=\"white-space:nowrap\">DE20<a name=\"HIV.Configuration-DE20\"> </a></td><td>Reporting period end date</td><td>End date of the reporting period</td></tr><tr><td style=\"white-space:nowrap\">DE21<a name=\"HIV.Configuration-DE21\"> </a></td><td>Reporting period start date</td><td>Start date of the reporting period</td></tr><tr><td style=\"white-space:nowrap\">DE22<a name=\"HIV.Configuration-DE22\"> </a></td><td>Reporting date</td><td>Reporting date, for surveys performed on a specific date</td></tr></table></div>"
  },
  "url" : "http://worldhealthorganization.github.io/smart-hiv/CodeSystem/HIV.Configuration",
  "version" : "0.1.0",
  "name" : "HIV_Configuration",
  "title" : "HIV.Configuration CodeSystem",
  "status" : "draft",
  "experimental" : false,
  "date" : "2024-03-05T17:44:29+00:00",
  "publisher" : "WHO",
  "contact" : [{
    "name" : "WHO",
    "telecom" : [{
      "system" : "url",
      "value" : "http://who.int"
    }]
  }],
  "description" : "CodeSystem for HIV.Configuration  Data Elements",
  "caseSensitive" : false,
  "content" : "complete",
  "count" : 22,
  "concept" : [{
    "code" : "DE1",
    "display" : "Population prevalence of TB",
    "definition" : "The tuberculosis prevalence in the general population in number of cases per 100 000 persons or greater."
  },
  {
    "code" : "DE2",
    "display" : "Population prevalence of soil-transmitted helminth infection",
    "definition" : "The percentage of individuals in the general population infected with at least one species of soil-transmitted helminths"
  },
  {
    "code" : "DE3",
    "display" : "Population incidence of HIV in the absence of PrEP",
    "definition" : "HIV incidence number of cases per 100 person–years in the absence of PrEP"
  },
  {
    "code" : "DE4",
    "display" : "Population prevalence of HIV",
    "definition" : "The proportion of the population that are HIV-positive"
  },
  {
    "code" : "DE5",
    "display" : "Prevalence of pretreatment NNRTI drug resistance",
    "definition" : "Prevalence of pretreatment HIV drug resistance to NNRTIs among people initiating first-line ART"
  },
  {
    "code" : "DE6",
    "display" : "Malaria-endemic setting",
    "definition" : "Whether the setting is a malaria-endemic setting"
  },
  {
    "code" : "DE7",
    "display" : "Population prevalence of syphilis",
    "definition" : "The proportion of the population with syphilis"
  },
  {
    "code" : "DE8",
    "display" : "Population prevalence of hepatitis B",
    "definition" : "The proportion of hepatitis B surface antigen (HBsAg) seroprevalence in the general population"
  },
  {
    "code" : "DE9",
    "display" : "Population prevalence of hepatitis C",
    "definition" : "The proportion of hepatitis C virus (HCV) antibody seroprevalence in the general population"
  },
  {
    "code" : "DE10",
    "display" : "Prevalence of HIV in the catchment area",
    "definition" : "The proportion of the population from the health facility's catchment area that are HIV-positive (estimated)"
  },
  {
    "code" : "DE11",
    "display" : "Ultrasound available at the health facility",
    "definition" : "Whether an ultrasound machine is available and functional in the facility and a trained health worker is available to use it"
  },
  {
    "code" : "DE12",
    "display" : "HIV burden of the setting",
    "definition" : "HIV burden of the setting (high or low) based on the national HIV prevalence or where the HIV prevalence and/or incidence in a geographical setting is higher than national prevalence and, therefore, needs priority in the HIV response"
  },
  {
    "code" : "DE13",
    "display" : "High HIV burden setting",
    "definition" : "Settings with >5% national HIV prevalence and subpopulations and geographic settings where HIV prevalence and/or incidence is higher than nationally."
  },
  {
    "code" : "DE14",
    "display" : "Low HIV burden setting",
    "definition" : "Settings with <5% HIV national prevalence but where certain populations (primarily key populations and their partners) and geographic settings may have higher HIV prevalence and/or incidence than nationally and, therefore, need priority in the HIV response"
  },
  {
    "code" : "DE15",
    "display" : "HPV DNA testing operational at the health facility",
    "definition" : "Is HPV DNA testing operational at the health facility for cervical cancer screening?"
  },
  {
    "code" : "DE16",
    "display" : "Routine viral load testing is available",
    "definition" : "Routine viral load testing is available in the facility"
  },
  {
    "code" : "DE17",
    "display" : "Health facility ID",
    "definition" : "Unique ID of the health facility that recorded the client. This ID could represent a universal health facility ID, if used in the country. Alternatively this ID can also be generated by the national surveillance system and assigned to reporting facility."
  },
  {
    "code" : "DE18",
    "display" : "TB treating facility ID",
    "definition" : "The facility where the client is receiving tuberculosis (TB) treatment"
  },
  {
    "code" : "DE19",
    "display" : "Other priority populations",
    "definition" : "Other populations of priority of HIV prevention and care in local context (provided during adaptation)"
  },
  {
    "code" : "DE20",
    "display" : "Reporting period end date",
    "definition" : "End date of the reporting period"
  },
  {
    "code" : "DE21",
    "display" : "Reporting period start date",
    "definition" : "Start date of the reporting period"
  },
  {
    "code" : "DE22",
    "display" : "Reporting date",
    "definition" : "Reporting date, for surveys performed on a specific date"
  }]
}